Skip to main content
. 2009 Dec 4;23(4):259–265. doi: 10.3341/kjo.2009.23.4.259

Fig. 1.

Fig. 1

Comparison of the clinical course of best corrected visual acuity between the bevacizumab-injected eyes and triamcinolone acetonide-injected eyes in patients with macular edema secondary to branch retinal vein occlusion. The asterisk (*) indicates a statistically significant changes (p<0.05) from baseline within group, the dagger (†) means statistically significant difference (p<0.05) between the bevacizumab and triamcinolone-injected eyes at each time point.